| Bertini G, Dani C, Tronchin M et al. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001; 107:(3)E41. | No analysis for confounding variables |
| Beutner D, Foerst A, Lang-Roth R et al. Risk factors for auditory neuropathy/auditory synaptopathy. ORL 2007; 69:(4)239–44. | No adjustment for confounding variables |
| Bhutani VK and Johnson LH. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns. Journal of Perinatology 2001; 21 Suppl 1:S76-S82. | Overview |
| Bhutani VK. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Journal of Pediatrics 2005; 147:(1)123–4. | Synopsis |
| Blackmon LR, Fanaroff AA, and Raju TNK. Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary. Pediatrics 2004; 114:(1)229–33. | Overview of jaundice research |
| Brites D, Fernandes A, Falcao AS et al. Biological risks for neurological abnormalities associated with hyperbilirubinemia. J Perinatol 0 AD; 29:(S1)S8-S13. | Overview - Background |
| Cronin CM, Brown DR, and hdab-Barmada M. Risk factors associated with kernicterus in the newborn infant: importance of benzyl alcohol exposure. American Journal of Perinatology 1991; 8:(2)80–5. | Benzyl alcohol as a risk factor for kernicterus |
| De Vries LS, Lary S, Whitelaw AG et al. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Human Development 1987; 15:(5)269–77. | Outcome not of interest to this guideline |
| Ding G, Zhang S, Yao D et al. An epidemiological survey on neonatal jaundice in China. Chinese Medical Journal 2001; 114:(4)344–7. | No adjustment for confounding variables |
| Frishberg Y, Zelicovic I, Merlob P et al. Hyperbilirubnemia and influencing factors in term infants. Israel Journal of Medical Sciences 1989; 25:(1)28–31. | Confounders not controlled for |
| Gagnon AJ, Waghorn K, Jones MA et al. Indicators nurses employ in deciding to test for hyperbilirubinemia. JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing 2001; 30:(6)626–33. | Background |
| Gartner LM and Arias IM. Studies of prolonged neonatal jaundice in the breast-fed infant. Journal of Pediatrics 1966; 68:(1)54–66. | No adjustment for confounders |
| Geiger AM, Petitti DB, and Yao JF. Rehospitalisation for neonatal jaundice: risk factors and outcomes. Paediatric and Perinatal Epidemiology 2001; 15:(4)352–8. | Risk factors for jaundice readmission – confounders not controlled for |
| Gourley GR. Another risk factor for neonatal hyperbilirubinemia. Journal of Pediatric Gastroenterology and Nutrition 2005; 40:(3)388–9. | Synospis |
| Grupp-Phelan J, Taylor JA, Liu LL et al. Early newborn hospital discharge and readmission for mild and severe jaundice. Archives of Pediatrics and Adolescent Medicine 1999; 153:(12)1283–8. | Effect of early discharge on jaundice readmission rates |
| Guo X, Pu X, An T et al. Characteristics of brainstem auditory evoked potential of neonates with mild or moderate hyperbilirubinemia. Neural Regeneration Research 2007; 2:(11)660–4. | No comparison group |
| Hall RT, Simon S, and Smith MT. Readmission of breastfed infants in the first 2 weeks of life. Journal of Perinatology 2000; 20:(7)432–7. | Risk factors for readmission of breastfed babies |
| Harris MC, Bernbaum JC, Polin JR et al. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001; 107:(5)1075–80. | Developmental follow-up of babies with bilirubin > 451 micromol/litre |
| Huang MJ, Kua KE, Teng HC et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatric Research 2004; 56:(5)682–9. | Only breastfeeding and genetic risk factors considered |
| Iranpour R, Akbar MR, and Haghshenas I. Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates. Indian Journal of Pediatrics 2003; 70:(11)855–7. | G6PD deficiency as a risk factor for jaundice |
| Johnson L. Hyperbilirubinemia in the term infant: When to worry, when to treat. New York State Journal of Medicine 1991; 91:(11)483–9. | Overview |
| Kaplan M, Bromiker R, Schimmel MS et al. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. Journal of Pediatrics 2007; 150:(4)412–7. | Effect of discharge management on readmission rates |
| Kaplan M, Herschel M, Hammerman C et al. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. Journal of Pediatrics 2006; 149:(1)83–8. | Study restricted to African-American males babies |
| Madlon-Kay DJ. The clinical significance of ABO blood group incompatibility. Archives of Family Medicine 1993; 2:(3)285–7. | ABO incompatibility as a risk factor for jaundice |
| Maisels MJ and Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 1998; 101:(6)995–8. | Risk factors for readmission for jaundice – confounders not controlled for |
| Nakamura H. Assessing the risk of kernicterus. Indian Journal of Pediatrics 1987; 54:(5)625–31. | Unbound bilirubin as a risk factor for kernicterus |
| Ogun B, Serbetcioglu B, Duman N et al. Long-term outcome of neonatal hyperbilirubinaemia: subjective and objective audiological measures. Clinical Otolaryngology and Allied Sciences 2003; 28:(6)507–13. | Long-term sequelae of hyperbilirubinaemia |
| Olusanya BO, Akande AA, Emokpae A et al. Infants with severe neonatal jaundice in Lagos, Nigeria: Incidence, correlates and hearing screening outcomes. Tropical Medicine and International Health 2009; 14:(3)301–10. | Effect of severe neonatal jaundice on hearing outcomes |
| Paul IM, Lehman EB, Hollenbeak CS et al. Preventable newborn readmissions since passage of the Newborns' and Mothers' Health Protection Act. Pediatrics 2006; 118:(6)2349–58. | Predictors of readmission after hospital discharge |
| Paul IM, Phillips TA, Widome MD et al. Cost-effectiveness of postnatal home nursing visits for prevention of hospital care for jaundice and dehydration. Pediatrics 2004; 114:(4)1015–22. | Not relevant to this quideline |
| Phuapradit W, Chaturachinda K, and Auntlamai S. Risk factors for neonatal hyperbilirubinemia. Journal of the Medical Association of Thailand 1993; 76:(8)424–8. | No regression analysis |
| Sales de Almeida F, Pialarissi PR, Monte AA et al. Otoacoustic emissions and ABR: Study in hyperbilirubinemic newborns. Revista Brasileira de Otorrinolaringologia 2002; 68:(6)851–7. | Outcome not of interest to this guideline |
| Sarici SU, Serdar MA, Korkmaz A et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004; 113:(4)775–80. | Not adjustment for confounding variables |
| Setia S, Villaveces A, Dhillon P et al. Neonatal jaundice in Asian, white, and mixed-race infants. Archives of Pediatrics and Adolescent Medicine 2002; 156:(3)276–9. | Ethnicity (at least one Asian parent) as a risk factor for jaundice |
| Shah VA and Cheo LY. Identifying risk of neonatal hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns in Singapore. Annals of the Academy of Medicine Singapore 2007; 36:(12)1003–9. | G6PD deficient babies only |
| Stiehm ER and Ryan J. Breast-milk jaundice. Report of eight cases and effect of breast feeding on incidence and severity of unexplained hyperbilirubinaemia. American Journal of Diseases of Children 1965; 109:212–6. | Case-studies |
| Thoma J, Gerull G, and Mrowinski D. A long-term study of hearing in children following neonatal hyperbilirubinemia. Archives of Oto-Rhino-Laryngology 1986; 243:(2)133. | Non-comparative study |
| Tudehope D, Bayley G, Munro D et al. Breast feeding practices and severe hyperbilirubinaemia. Journal of Paediatrics and Child Health 1991; 27:(4)240–4. | Link between breastfeeding and early onset jaundice |
| van de Bor M, Ens-Dokkum M, Schreuder AM et al. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics 1992; 89:(3)359–64. | Outcome, at 5 year, of low-birthweight babies with hyperbilirubinamia |
| van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP et al. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: Results of a national collaborative survey. Pediatrics 1989; 83:(6)915–20. | Long term sequelae of hyperbilirubinaemia in preterm babies |
| Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clinics in Perinatology 1990; 17:(2)293–306. | Overview |
| Watchko JF. Neonatal hyperbilirubinemia -- what are the risks? New England Journal of Medicine 2006; 354:(18)1947–9. | Overview |
| Yaish HM, Niazi GA, Al S et al. Increased incidence of hyperbilirubinaemia in ‘unchallenged’ glucose-6-phosphate dehydrogenase deficiency in term Saudi newborns. Annals of Tropical Paediatrics 1991; 11:(3)259–66. | No adjustment for confounding variables |
| Young-Lewis LE. Factors contributing to the readmission of previously healthy low-risk neonates for hyperbilirubinemia. (CASE WESTERN RESERVE UNIVERSITY) **1996; PH.D 146. | PHd thesis |
